Alzheimer's drugs show trivial effects on cognitive decline, review finds

A comprehensive review of 17 clinical trials reveals that anti-amyloid drugs, considered a breakthrough for Alzheimer's treatment, show no significant impact on cognitive decline. The study indicates that improvements in cognition and functional ability are minimal over an 18-month period for patients with mild cognitive impairment or mild dementia.

Read the full story at The Guardian AU→